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Abstract 
Perineural invasion (PNI) is a common and characteristic feature of pancreatic ductal adenocarcinoma (PDAC) that is associated with poor prognosis, tumor recurrence and generation of pain. However, comprehensive analysis of the molecular alterations in both cancer cells and nerves within PNI is still lacking. 
We report the proteomic analysis of the molecular changes underlying neuro-epithelial interactions in PNI using liquid chromatography-mass spectrometry (LC-MS/MS) in microdissected PNI and non-PNI cancer, as well as invaded and non-invaded nerves from formalin-fixed, paraffin-embedded PDAC tissues. In addition, an in vitro model of PNI was developed using a co-culture system comprising PDAC cell lines and PC12 cells as the neuronal element.
The overall proteomic profiles of PNI and non-PNI cancer appeared largely similar. In contrast, upon invasion by cancer cells, nerves demonstrated widespread plasticity with a pattern consistent with neuronal injury. The upregulation of SCG2 (secretogranin II) and neurosecretory protein VGF (non-acronymic) in invaded nerves in PDAC tissues was further validated using immunohistochemistry.  Using our in vitro established co-culture model, the tested PDAC cell lines were able to induce neuronal plasticity in PC12 cells. Changes in expression levels of VGF, as well as two additional proteins previously reported to be overexpressed in PNI, Nestin and Neuromodulin (GAP43), closely recapitulated our proteomic findings in PDAC tissues. Furthermore, induction of VGF, while not necessary for PC12 survival, mediated neurite extension induced by PDAC cell lines. 
Our study identified comprehensive proteomic alterations underlying PNI in PDAC revealing widespread neural regulations. In addition, we describe a novel, simple and easily adaptable co-culture model for in vitro study of neuro-epithelial interactions.      


1. Background
Perineural invasion (PNI) is a characteristic feature of pancreatic adenocarcinoma (PDAC), which is, upon detailed histopathology examination, encountered in almost 100% of cases (Liu, 2002; Marchesi et al., 2010; Pour et al., 2003). PNI correlates with tumor recurrence  ADDIN EN.CITE (Chou et al., 2013; Liu, 2002; Kayahara et al., 1993; Kelsen et al., 1997; Shimada et al., 2011), is implicated in generation of pain (Bapat et al., 2011; D’Haese et al., 2014) and confers poor prognosis (Zhang et al., 2013). However, despite the first description of PNI more than 150 years ago (Demir et al., 2012a) and its doubtless importance, it is still the least studied route of metastatic spread, and our knowledge of the neuro-epithelial interactions in PDAC remains limited and fragmented. Recent reports indicated that the microenvironment created by this interaction provides a suitable milieu for tumor growth, resulting in enhanced proliferation and inhibition of apoptosis as well as increased migration of cancer cells (Bapat et al., 2011; Dai et al., 2007). At the same time, akin to neoangiogenesis and lymphangiogenesis, tumor cells also promote neoneurogenesis, manifested in increased nerve hypertrophy and neural density in human PDAC tissues (Ceyhan et al., 2009a). The presence and implication of alterations in the neuronal structure and/or function, i.e. neuronal remodelling and plasticity, in the context of cancer are increasingly recognised (Demir et al., 2015). Moreover, neuroplastic changes are seen in early development of PDAC with ablation of sensory neurons leading to slower development of PanINs (pancreatic intraepithelial neoplasia) (Saloman et al., 2016), while in contrast, subdiaphragmatic vagotomy in LSL-Kras+/G12D;Pdx1-Cre (KC) mice accelerated PDAC development (Renz et al, 2018a). Furthermore, antibody targeting of NGF (nerve growth factor) or small molecule blocking of NGF-Trk pathway led to inhibition of cancer progression and increased overall mice survival in LSL-Kras+/G12D;LSL-Trp53+/R172H;Pdx1-Cre (KPC) mouse model (Saloman et al., 2018; Renz et al., 2018b). These findings confirm the important and active role of the nervous system in both PDAC development and progression as well as its potential for therapeutic targeting (Demir et al., 2012b; Jobling et al., 2015; Mancino et al., 2011; Pour et al., 2003; Stopczynski et al., 2014; Saloman et al., 2016). 
Most of the observations on PNI were made using a currently limited number of in vitro and in vivo models (Demir et al., 2012a; Liebig et al., 2009; Amit et al., 2016; Deborde et al., 2018), and very few large-scale studies of PNI tissues have been performed until now: gene expression of microdissected PNI and non-PNI salivary adenoid cystic carcinoma cells (Chen et al., 2007), and gene and microRNA profiles were analysed in bulk prostate cancer tissues from cases with or without PNI (Prueitt et al., 2008). In the pancreas, transcriptome and proteome of high and low nerve-invasive PDAC cell lines injected in NOD/SCID (nonobese diabetes/severe combined immunodeficient) mice were described (Abiatari et al., 2009; Hibi et al., 2009; Koide et al., 2006), but no large scale molecular data from cancer cells or nerves within PNI tissues are available as yet. Here, we report on global proteomic analysis of laser microdissected, matched PNI and non-PNI cancer as well as invaded and non-invaded nerves from human formalin-fixed, paraffin-embedded (FFPE) tissues. In addition, we developed an in vitro model that successfully recapitulated several phenotypic and molecular alterations observed in PNI in human PDAC tissues.

2. Materials and Methods
2.1 Tissues and cell lines
Normal and PDAC tissues were collected and obtained from the Department of Histopathology, Royal London Hospital (London, UK), Department of Pathology and Forensic Medicine (Osijek, Croatia) and from European Pancreas Centre Research Laboratory at the University of Heidelberg (Heidelberg, Germany).  All tissues were obtained with full ethical approval from the respective Institutional Boards and used in accordance with the Human Tissue Act 2004. 
PDAC cell lines (MiaPaca2, BxPC3 and Capan1) were obtained from Cancer Research UK Tissue Culture Service and routinely cultured in Dulbecco's Modified Eagle Medium, DMEM, (Invitrogen, Paisley, UK) supplemented with 10% heat-inactivated fetal calf serum, FCS (Autogen Bioclear, Wiltshire, UK) and penicillin/streptomycin at 37°C in 5% CO2. PC12 cells, a rat pheochromocytoma cell line, were a kind gift from Dr Lesley Robson (Blizard Institute, QMUL London), and were grown in poly-D-lysine hydrobromide (PDL; MW 30,000-70,000, Sigma, P7886) coated tissue culture flasks in RPMI media supplemented with 10% heat-inactivated horse serum, 5% heat-inactivated FCS and penicillin/streptomycin at 37°C in 5% CO2.  The identity of the cell lines utilised was confirmed by STR profiling.
2.2 Tissue section preparation and laser microdissection
10µm sections were cut from each of five FFPE PDAC blocks (PDAC 1-5, Table S1) and mounted on PEN membrane slides (Zeiss, Germany) (Figure S1). Every fifth section was cut at 5µm, routinely stained with H&E and reviewed to determine areas for laser microdissection. After baking in an oven at 55°C for 45min, sections on PEN slides were deparaffinised using xylene and rehydrated in graded ethanol, stained with hematoxylin and dehydrated through graded ethanol followed by xylene and air-drying for 5min. The staining procedure was completed in 15min. Laser microdissection was performed using PALM instrument (Zeiss, Germany). PNI cancer, non-PNI cancer, invaded nerves and non-invaded nerves were separately dissected from each of the five pancreatic cancer cases and stored at -20°C.
2.3 Protein extraction for proteomics analysis
Laser microdissected samples (approximately 30,000 cells) were resuspended in 20µl Liquid Tissue buffer (Expression Pathology, Inc., USA), and protein extraction and digestion performed according to manufacturer’s instructions. Briefly, samples were boiled for 90min at 95°C, cooled on ice, and digested overnight at 37°C with sequencing grade trypsin (Promega, USA) (1µg/20µl buffer). Peptide concentration was measured with Micro BCA kit (Thermo Fisher Scientific, USA), and DTT (10mM final concentration) was then added and samples boiled at 95°C for 5min before storing at -20°C until further analysis. 
2.4 Proteomics analysis and data processing
LC-MS/MS was performed (MSBioworks, USA) on a Nanoacuity LC system coupled to LTQ Orbitrap Velos platform (Thermofisher, USA) using 1µg peptide digests of each of the five matched PNI and non-PNI cancers and invaded and non-invaded nerves, in duplicate.  Buffer A was 0.1% FA in water, and buffer B was 0.1% FA in acetonitrile. Samples were suspended in 0.1%FA were first loaded on an IntegraFrit trap column (75µm x 30mm) packed with Jupiter Proteo C12 material with 5µm particle size (Thermofisher Scientfic, USA). Peptides were then eluted from a 75µm x 250mm, 4µm particle Jupiter Proteo C12 analytical column (Phenomex, CA, USA) at 350nl/min using 5-22%B over 70min then to 35%B over 20min and to 85%B over 15min. Total run time was 2 hours/sample. Data was acquired over mass range 300-1600 in a data-dependent manner. Each full MS scan was followed by MS/MS of the 15 most abundant ions, dynamic exclusion and repeat settings ensured each ion was selected only once and excluded for 30s thereafter. 
MS data was analyzed using MaxQuant version 1.4.0.1 (Cox, Mann, 2008). The proteins were identified by searching MS and MS/MS data of peptides against the Swissprot human canonical database (20,556 entries) appended with common contaminants using the Andromeda search engine. Oxidation of methionine and protein N-terminal acetylation were chosen as variable modifications. The minimum peptide length was specified to be seven amino acids. The initial maximal mass tolerance in MS mode was set to 7 ppm, whereas fragment mass tolerance was set to 0.5 Da for fragmentation data. The maximum false protein and peptide discovery rate (FDR) was specified as 0.01 and determined using a decoy database. Proteins were identified with ≥2 peptides/protein. 
2.5 Immunohistochemistry (IHC)
Basic clinico-pathological data of FFPE tissue samples used for  IHC analysis is summarised in supplementary Table S1. 4µm tissue sections were stained using rabbit anti-SCG2 primary antibody (dilution 1:500 HPA011893 Prestige Antibodies, Sigma-Aldrich) and anti-VGF primary antibody (1/400 dilution, Abcam ab69989; Milton Cambridge, UK). SCG2 IHC was performed in Ventana Discovery automated system, while VGF was performed manually with Vectastain ABC kit (Vector Labs, Peterborough, UK) according to the manufacturer’s instructions. Staining intensity was semi-quantitatively assessed at 200x magnification as absent (0), weak (1), moderate (2) or strong (3).
 
2.6 Western blotting 
Cell lysis was performed using NP40 buffer (1% NP40, 50 mM Tris pH7.4, 150 mM NaCl) with protease inhibitors (Roche Diagnostics, West Sussex, UK). 25 g of protein lysate were analysed by SDS-PAGE as previously described (Whiteman et al., 2007).
Following antibodies were used: Goat anti-VGF (Santa Cruz, R-15:sc-10383; Germany) 1:800; rabbit anti-GAP43 (Abcam ab16053, Milton Cambridge, UK) 1/20,000; mouse anti-GAPDH (Santa Cruz, Germany) 1/20,000; mouse anti-Nestin, (Abcam, Milton Cambridge, UK), 1:200; rabbit anti-Caspase 3 (Cell Signalling, 9662S; Netherland) 1:400). Band intensities were quantified in Image J (National Health Institute, https://imagej.nih.gov/ij/) relative to the intensity of the GAPDH in the same sample. Densitometry results of three independent experiments were expressed as a fold change relative to the control samples.
2.7 PC12 co-culture experiments 
For the Transwell co-cultures, 1.5x105 PC12 cells were seeded in complete RPMI media in 6-well plates pre-coated with PDL. 1.5x105 PDAC or PC12 cells were also seeded in their respective media in 6-well plate inserts (1µm pore size, BD Biosciences, CA, USA) in separate plates. Next day, media was removed and cells in inserts and wells were washed three times with serum-free RPMI. Inserts with PC12 or PDAC cells were then combined with wells containing PC12 cells before adding serum-free RPMI to wells (2ml) and inserts (1ml). 24 hours later, phase-contrast photographs of PC12 cells in the wells were taken using an inverted Olympus CKX41 microscope (Olympus) at 200x magnification. PC12 cells were then harvested for RNA and protein extraction and flow-cytometry.
For the contact co-cultures, 1.2x106 PC12 cells were seeded in their complete RPMI media in T75 flasks pre-coated with PDL. Next day, media was removed and cells were incubated with fresh media containing 2.5µM CellTracker Green CMFDA (Invitrogen, Paisley, UK) at 37˚ for 30min. Cells were then washed twice with serum-free RPMI media and 1.2x106 PDAC or PC12 cells in complete RPMI media were added to the flasks. The added cells were then allowed to attach for 2 hours. Co-cultures were washed three times before adding 24ml of fresh serum-free RPMI. After 22 hours, cells were harvested, and CMFDA positive PC12 cells were separated using FACS. The positively sorted cells were checked again using FACS to verify purity and an aliquot of those cells was seeded on coverslips for additional immunocytochemical validation of their purity. 
Seeding density (~15,000 cells/1cm2), ratio of PDAC to PC12 cells (1:1) and ratio of media to cells (1ml/1.0x105) were kept constant and both co-cultures were performed and analysed in parallel.
2.8 Preparation of conditioned media
Conditioned media were prepared from 4x106 PDAC or PC12 cells after an overnight culture. Cells were washed three times before adding fresh serum-free RPMI for conditioning. 24 hours later, media were collected, centrifuged at 4,000g for 5min, filtered (0.22µm filters, Millipore, Cork, Ireland) and immediately used to treat PC12 cells.   
2.9 Quantitation of PC12 neurite growth
Randomly selected high power fields (three per well, at 200x magnification) of PC12 were analyzed for neurite growth in Image J. The degree of neurite extension was estimated by counting the number of cells bearing neurites longer than the maximum diameter of the cell body (Katoh et al., 2000).  At least 200 cells were counted in each well and results were expressed as percentage of total number of cells. Each experiment was performed at least three times.
2.10 Annexin V/DAPI flow-cytometry assay
Floating and attached cells were harvested, centrifuged and washed with ice cold PBS, pelleted and resuspended in 100µl Annexin binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4) containing 5µl of Annexin V Alexa Fluro 647 (Invitrogen, Paisley, UK). Following 15min incubation at room temperature in the dark, 400µl of the binding buffer containing 1µg/ml 4',6-diamidino-2-phenylindole (DAPI) was added to each sample. Flow-cytometry was immediately performed using BD Fortessa cell analyzer (BD Biosciences, CA, USA). PC12 cells growing in their complete media or serum-free RPMI were included as negative and positive controls, respectively. Cells negative for both Annexin V and DAPI were quantified as the surviving fraction and results were expressed relative to PC12 survival in complete media. Duplicate wells were analyzed within each experiment and experiments were repeated three times. 
2.11 RNA extraction, cDNA synthesis and qRT-PCR
Total RNA was extracted using RNAqueous kit (Ambion, CA, USA). 1µg of total RNA was reverse transcribed using Quantitech reverse transcription kit (Qiagen, West Sussex, UK). qRT-PCR was performed using SYBR green method on an ABI7500 cycler (Applied Biosystems, CA, USA). All primers were obtained from PrimerDesign (Southampton, UK). The VGF primer sequences were: forward 5’-TGAGACTTTGACACCCTTATCC and reverse 5’-GGAACCGCCCAGGAATGA. Run conditions were: 50˚C for 2min, 95˚C for 15min followed by 40 cycles of 95˚C for 15sec, 60˚C for30 sec and 72˚C for 1min. Data is presented as fold change relative to control after normalisation to the mean of housekeeping genes B2M and RPL13 (PrimerDesign proprietary primer sequences).
2.12 VGF silencing 
SiRNA knock-down of VGF in PC12 cells was performed using Lipofectamine RNAiMAX (Invitrogen, Paisley, UK) according to the manufacturer’s instructions. SiRNA targeting VGF (On target plus pool) or non-targeting siRNA (Dharmacon, Fisher Scientific, UK) were used at 1nM final concentration. This was optimised to block the induced VGF expression but to maintain the basal levels of VGF expression at 24 hours. Media was removed six hours later and cells were washed three times before incubation with PDAC or PC12 conditioned media for 24 hours.
2.13 Statistical analysis
Differential expression of proteins was assessed with Student’s t-test using peak intensity values for label-free relative quantitative analysis of the LC-MS/MS data. For continuous data, Student’s t-test was used to compare means of data whereas ANOVA with post-hoc correction for multiple comparisons was used when three or more samples were compared. For semiquantitative IHC data, Mann-Whitney test was used to compare the means whereas Kruskal-Wallis test with post-hoc correction for multiple comparisons was used when comparing more than two groups. Two-tailed p values were always calculated and results were plotted as mean ± standard error of mean (SEM). The statistical analysis was performed using GraphPad Prism 5.03 software. The significance level was set at p<0.05.
2.14 Data accessibility 
All data are provided with this submission and will be available freely after the acceptance of the manuscript.

3. Results
3.1 Proteomic analysis of cancer cells and nerves in PNI
In order to assess the molecular alterations in cancer cells within the perineural environment, LC-MS/MS analysis was performed on five matched PNI (cancer invading nerves) and non-PNI (primary) cancer samples (Table S1). Microdissected sample purity was > 96% for the PNI cancer and even higher for the nerve samples (Supplementary information 1). A total of 1,628 non-redundant proteins were identified (Table S2), of which 1,432 proteins were seen in perineural cancer cells from the PNI samples (1,083-1,266 per sample) and 1,542 proteins in cancer cells from the non-PNI samples (1,092-1,258 per sample). Only 31 proteins (1.9%) were differentially expressed (p≤0.05) (Table S3); when a fold change of ≥1.5 was applied in addition to the p value, only eight up-regulated and 11 down-regulated proteins were identified. Using unsupervised hierarchical cluster analysis based on all identified proteins, PNI and non-PNI samples obtained from each case were shown to cluster together, confirming further similar nature of these samples (Figure 1A). In parallel, LC-MS/MS analysis of invaded and non-invaded nerve samples from the same five PDAC cases resulted in identification of 923 unique proteins (Table S4). In the invaded nerves, 847 proteins (681-729 proteins per sample) and in the non-invaded nerves 833 proteins (578-729 proteins per sample) were identified; 167 proteins (18%) were found differentially expressed (p≤0.05) (Table S5). A list of 61 differentially expressed proteins selected for both p≤0.05 and fold change of ≥2 is provided in Table 1. Interestingly, unsupervised hierarchal clustering revealed that all invaded nerves (IN1-5) grouped together, and were separated from the four out of five non-invaded nerves (NIN2-5) (Figure 1B). This clustering pattern strongly suggested common underlying molecular changes upon neural invasion. While the reason for clustering of one of the non-invaded nerve samples, NIN-1, with invaded nerves could potentially be due to invasion of those nerves at a different depth in the tissue sample (or even in the adjacent tissue block), the observed clustering pattern strongly suggested common underlying molecular changes upon neural invasion. 
To identify enriched cellular functions and disease processes in invaded and non-invaded nerves, Ingenuity Pathway Analysis (IPA) was performed. ‘Neurological Diseases’ was the most enriched disease category in addition to ‘Immunological Diseases’ and ‘Inflammatory Response’ (data not shown). Analysis of molecular and cellular functions revealed enrichment in ‘Cell Death and Survival’ (Figure S2A), as well as ‘Cell Morphology’, ‘Cellular Growth and Proliferation’ and ‘Cell Movement’ functions, including several sub-categories related to neuritogenesis and axonal development, comprising proteins such as VGF, Neuromodulin (GAP43), Laminin B1 and C1 (LAMB1 and LAMC1), Tenascin (TNC), serine-threonine protein kinase DCLK1 and Microtubule Associated Protein 1B (MAP1B) (Figure S2B).
3.2 Expression of CSG2 and VGF in the nerves
Two of the highly up-regulated proteins in the invaded compared to non-invaded nerves (Table 1), Secretogranin-2 (CSG2) and neurosecretory protein VGF, were selected for further validation by immunohistochemistry. In normal pancreas, strong expression of both proteins was seen in the islets, while nerves were mostly devoid of any immunoreactivity (Figure 2A/G). Nerves in PDAC tissues however, showed a spectrum of CSG2 and VGF expression; the nerves outside the tumor/stromal mass did not usually express VGF (Figure 2B/H), nerves within the tumour showed weak to moderate expression (Figure 2C/I), while nerves invaded with cancer displayed in the majority of cases moderate to strong expression (Figure D/J) that was significantly higher than in non-invaded nerves (Figure 2E/K). Based on this observed pattern, we classified nerves into non-invaded extra-tumoral and intratumoral nerves, and invaded nerves; both CSG2 and VGF expression was significantly different between these three groups (Figure 2F/L). These data are consistent with the proteomics results and suggests a role for PDAC cells in the induction of both proteins in pancreatic nerves.
3.3 In vitro modelling of neuronal plasticity in PNI
In order to further validate molecular changes observed in proteomic analysis and facilitate characterisation of underlying molecular mechanisms in PNI, we established an in vitro co-culture model, using PC12 cells as the neuronal element. PC12 is a rat pheochromocytoma cell line which on exposure to NGF differentiates into sympathetic-like neurons, exits the cell cycle, extends neurites and becomes electrically excitable (Greene, Tischler, 1976).  As the pancreas is innervated chiefly by the autonomic nervous system (sympathetic and parasympathetic) in addition to the intrinsic pancreatic ganglia (Kiba, 2004; Salvioli et al., 2002),  PC12 cells represent an attractive model for these nerves. All three tested PDAC cell lines, MiaPaca2, Capan1 and BxPc3 induced neurite extension in PC12 cells in the Transwell co-culture system, similar to that induced by NGF (Figure 3A, B). The same cell lines also protected PC12 cells from serum-starvation induced apoptosis, as measured by Annexin V/DAPI (Figure 3C, D). In agreement with this, we observed an abrogation in the levels of cleaved Caspase-3 (CASP3) in PC12 cells when co-cultured with MiaPaca2, Capan1 and BxPc3 using the Transwell co-culture system, which was comparable to the effect of NGF (Figure 3E). These results indicate that PDAC cells were able to induce neuronal plasticity in PC12 cells similar to that observed in PNI.
Next, we assessed whether this model can also recapitulate the molecular changes seen in our proteomic analysis; because of its role in neruonal plasticity (Alder et al., 2003), we also tested VGF expression: Western blot showed two-fold increase in VGF expression in PC12 cells co-cultured with MiaPaca2, Capan1 and BxPC3 cells in the Transwell co-cultures (Figure 4A and B). Similar results were obtained at the mRNA level using qRT-PCR (Figure S3). We also investigated whether PDAC cell lines are able to induce the expression of other up-regulated proteins in invaded nerves seen in our proteomic analysis, Neuromodulin (GAP43) and Nestin (NES), as they have been previously linked with neuronal plasticity and their expression shown to be increased in nerves in PDAC using IHC   ADDIN EN.CITE (Ceyhan et al., 2009a; Kawamoto et al., 2009; Lenz et al., 2011). Indeed, the expression of both proteins significantly increased in PC12 cells co-cultured with Capan1 or BxPc3 cells (Figure 4A,C,D). 
Because our IHC analysis suggested a stronger induction of VGF immunoreactivity in the nerves as they come in close contact with cancer cells, we went on to verify if in vitro contact co-culture system could recapitulate this pattern of VGF expression.  PC12 isolated from the contact co-culture using FACS resulted in purity of the samples of 97% ±1.6 (mean ± SD) (Figure S4), and anti-CK19 antibody immunocytochemistry showed a purity of >99% (Figure S5). Similar to the observation in Transwell co-cultures, PDAC cell lines in the contact co-culture protected PC12 cells from serum-starvation-induced apoptosis (Figure 5A). Interestingly, approximately two-fold increase in the induction of VGF in PC12 cells was seen in contact compared to Transwell co-cultures (Figure 5B,C). This is therefore reminiscent of VGF expression pattern observed in pancreatic nerves in the context of PDAC.
As VGF is known to play a role in cell survival (Severini et al., 2008) and neuronal plasticity (Alder et al., 2003), and its expression appears to mirror PC12 survival and neurite extension, we next tested whether VGF could mediate some of these phenotypic changes in vitro. While targeting VGF with specific siRNA successfully blocked its up-regulation (Figure 6A), this had no repercussion on survival of PC12 cells (Figure 6B). However, PDAC cells-induced neurite extension in PC12 cells was significantly attenuated after blocking VGF induction (Figure 6C), indicating a functional role for VGF in the observed neuronal plasticity. 
Taken together, data from our co-culture system corroborates the proteomic profiling and IHC findings, confirms the ability of PDAC cells to induce neuronal plasticity, and reveals a functional role for VGF in this neuroepithelial interaction.  

4. Discussion 
Combining laser microdissection and proteomics approach has enabled us to perform the first direct characterisation of the protein alterations in both cancer cells and nerves in the context of PNI in human PDAC. In the studies that investigated PNI and non-PNI cancer cells using human tissues from cancers other than PDAC (Chen et al., 2007; Prueitt et al., 2008), a small number of differentially regulated genes was reported (none of these are in common with our proteomics data). While further in-depth approach might be needed to reveal potentially subtler proteomic changes in cancer cells upon PNI in PDAC, these previous reports are confirmatory of largely similar profiles in PNI and non-PNI cancer seen in our study.
In contrast, the analysis of the invaded and non-invaded nerves in PDAC revealed significant changes in their proteomic profiles, which in silico analysis highlighted to be a manifestation of neuronal plasticity. Interestingly, several up-regulated proteins found here, including VGF and GAP43, Pituitary adenylate cyclase-activating polypeptide (ADCYAP1), Laminin A (LAMA), Nestin (NES) and TNC have previously been shown to be up-regulated in peripheral nerve injury (Costigan et al., 2002; Kim et al., 2009; Matsumura et al., 2010; Valder et al., 2003) and thus provides a molecular basis of the long-described electron microscopy finding of nerve injury present within PNI (Bockman et al., 1994). 
We identified several extracellular proteins as up-regulated in invaded compared to non-invaded nerves (some of these were also seen in PNI compared to non-PNI cancer), including laminins LAMA2, LAMB1, COL6A3, periostin (POST), nidogen 1 (NID1) and TNC. These are constitutive components of the extracellular milieu/matrix within which cancer cells and nerves are interacting, and some of them have dual roles in promoting both cancer growth as well as neurogenesis. This supports the concept that the PNI environment offers beneficial growth conditions for both cancer and nerves (Mancino et al., 2011). 
Our proteomics analysis and IHC validation highlighted an increased expression of SCG2 and VGF in invaded compared to non-invaded nerves. Interestingly, the expression of both proteins increased as the nerves became closer to the cancer, which is consistent with previous observation of increasing neuroplasticity depending on the proximity of nerves to cancer (Ceyhan et al., 2010). SCG2 (Secretogranin II, Chromogranin C) is ~ 71kDa protein that belongs to the chromogranin-secretogranin family of acidic glycoproteins; it is expressed in secretory granules in a wide variety of peptides-secreting cells throughout central nervous system, in scattered endocrine cells in stomach and duodenum and in pancreatic islets, as well as in neuronal elements throughout the intestinal wall (Rosa et al., 1985; Boonen et al., 2007). It is a principal target of REST (RE-1 silecing transcription factor), an important regulator of neuronal differentiation which controls neurogenesis by preventing the differentiation of neural stem cells (Kim et al., 2015). SCG2 is a precursor for several peptides. One of them, EM66 is a 66-amino acid anorexigenic neuropeptide that might be involved in regulation of feeding behaviour and energy balance (Trebak et al., 2017); a 33-amino acid neuropeptide called secretoneurin, on the other hand, promotes neurite outgrowth and repair of neuronal tissues (Shyu et al., 2008). 
Similarly, VGF is expressed in both central and peripheral nervous system as well as in neuroendocrine cells in the gut (Levi et al., 2004; Lewis et al., 2015; Rindi et al., 2007; Salton et al., 2000). Its expression is regulated by neurotrophins during synaptic remodelling and axonal sprouting, and it is implicated in neuronal cell survival and plasticity  ADDIN EN.CITE (Alder et al., 2003; Severini et al., 2008; Shimazawa et al., 2010). Furthermore, akin to SCG2, VGF is also cleaved into several  biologically active neuropeptides, expression of which vary between different tissues. Several VGF peptides were demonstrated to regulate nutrition and energy homeostasis, metabolism and body weight (Bartolomucci et al., 2007; Watson et al., 2005). Furthermore, a central mechanistic role of VGF in neuropathic hypersensitivity and neuropathic pain has also recently been established (Ferri et al., 2011; Moss et al., 2008; Riedl et al., 2009), and it remains to be seen if VGF can be involved in generation of pain in PDAC patients as well. 
Interestingly, this additional layer of functional complexity due to production of physiologically active peptides from both SCG2 and VGF is probably also the case in PDAC, which is corroborated in our proteomic dataset by the up-regulation of PCSK1 in invaded nerves (Table 1), a known modulator of prohormone convertase 1 (PC1), which in turn is an enzyme responsible for both SCG2 and VGF processing. 
In order to establish a simple and reproducible in vitro model of PNI, we have co-cultured PC12 cells with PDAC cell lines. We show that tested PDAC cell lines were able to recapitulate the major phenotypic features of neuronal plasticity observed in tissues, namely nerve cell survival and neuritogenesis. PC12 cells undergo apoptosis in serum-free media; NGF, bFGF and cAMP, known inducers of VGF have been shown to protect these cells from serum starvation-mediated apoptosis (Rukenstein et al., 1991). We have therefore explored this further. While in our in vitro conditions VGF did not appear to mediate the survival of PC12 cells, blocking VGF induction resulted in significant reduction in neurite extension induced by both MiaPaca2 and BxPc3 conditioned media. This indicated that whilst VGF is induced as part of the neuroplasticity response, being a secreted protein, it may also augment this process in an autocrine/paracrine fashion. While these experiments serve as a proof of principle and initial validation of usefulness of our in vitro model, further mechanistic studies detailing the roles of VGF (as well as SCG2) in PNI are now warranted. 
Importantly, our model recapitulated several molecular changes observed in the proteomic analysis.  PDAC cells were able to induce VGF expression mimicking the VGF induction in human tissues and also demonstrated their ability to up-regulate VGF independently of any stromal influence. Interestingly, the up-regulation of VGF in PC12 cells was even higher when they were in direct contact with cancer cells, which could be due to either exposure of PC12 cells to locally higher concentration of soluble paracrine factors or direct cell-to-cell communication. In addition to VGF, PDAC cell lines were also able to induce GAP43 as well as NES expression in PC12 cells, which was again consistent with our proteomics data. Both proteins have been shown previously by IHC to be expressed in nerves in PDAC (Ceyhan et al., 2009a; Lenz et al., 2011; Kawamoto et al., 2009). The induction of NES is particularly interesting, as it is a stem cell marker that is usually absent in adult post-mitotic neuronal cells, indicating de-differentiation response to nerve injury; its up-regulation is also correlated with pain (Ceyhan et al., 2009b).
The functional and molecular alterations in PDAC cells in our co-culture system still remain to be investigated. However, the flexibility of this model with regard to introducing different cellular components, performing gene manipulation and ease of collecting sufficiently large quantities of conditioned media from both cancer and PC12 cells (or any additional stromal or immune cellular component) can undoubtedly facilitate such investigations and underscores the advantages of this model when compared to primary neuronal cells and neural tissue explants. It would now be interesting to further develop this culture as a 3D model.
5. Conclusions
 Here, we report on the first proteomes of both epithelial and neural components of PNI in human tissues and show that nerves invaded by pancreatic cancer undergo dramatic changes, manifested in neuronal plasticity, consistent with nerve injury. Some of the former changes were further successfully recapitulated in the developed in vitro co-culture model, indicating a complex and intricate neuroepithelial crosstalk instigated during perineural invasion in pancreatic cancer. 
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Tables

Table 1. List of proteins differentially regulated in invaded nerves compared to non-invaded nerves (p<0.05 and FC > 2.0). The mean of peak intensity values from five samples is shown.  IN: invaded nerves, NIN: non-invaded nerves. FC: fold change


Protein ID	Gene name	Protein name	IN	NIN	p value	FC
						
P51659	HSD17B4	Peroxisomal multifunctional enzyme type 2	2.0E+06	0.0E+00	0	 
O00231	PSMD11	26S proteasome non-ATPase regulatory subunit 11	4.0E+06	0.0E+00	0.0001	 
P50440	GATM	Glycine amidinotransferase, mitochondrial	2.0E+06	0.0E+00	0.0005	 
P02647	APOA1	Apolipoprotein A-I	2.0E+08	6.0E+08	0.001	0.4
P04040	CAT	Catalase	3.0E+07	6.0E+07	0.0012	0.4
P59768	GNG2	Guanine nucleotide-binding protein G subunit gamma-2	2.0E+07	7.0E+06	0.0017	2.3
P11166	SLC2A1	Solute carrier family 2	7.0E+06	5.0E+07	0.0036	0.2
P07339	CTSD	Cathepsin D	6.0E+07	3.0E+07	0.0037	2.0
Q8TAT6	NPLOC4	Nuclear protein localization protein 4 homolog	2.0E+07	2.0E+06	0.004	8.1
P54577	YARS	Tyrosine--tRNA ligase, cytoplasmic	2.0E+06	3.0E+05	0.004	7.6
P48681	NES	Nestin	4.0E+08	1.0E+08	0.0048	3.4
P13521	SCG2	Secretogranin-2	3.0E+07	3.0E+06	0.0064	9.6
P19971	TYMP	Thymidine phosphorylase	6.0E+07	2.0E+07	0.0064	2.4
P08294	SOD3	Extracellular superoxide dismutase [Cu-Zn]	3.0E+06	1.0E+07	0.0069	0.2
Q00325	SLC25A3	Phosphate carrier protein, mitochondrial	8.0E+06	2.0E+06	0.0072	3.4
P68871	HBB	Hemoglobin subunit beta;LVV-hemorphin-7	1.0E+09	8.0E+09	0.0078	0.2
P01857	IGHG1	Ig gamma-1 chain C region	1.0E+08	3.0E+08	0.0079	0.4
P21796	VDAC1	Voltage-dependent anion-selective channel protein 1	1.0E+07	5.0E+06	0.008	2.4
P02730	SLC4A1	Band 3 anion transport protein	6.0E+05	1.0E+07	0.0083	0.0
O15240	VGF	Neurosecretory protein VGF	1.0E+08	3.0E+07	0.0086	5.2
P24821	TNC	Tenascin	5.0E+07	2.0E+07	0.0088	2.6
P11277	SPTB	Spectrin beta chain, erythrocyte	2.0E+05	2.0E+06	0.0098	0.1
Q9HCJ6	VAT1L	Synaptic vesicle membrane protein VAT-1 homolog-like	2.0E+07	5.0E+06	0.0111	2.8
P45880	VDAC2	Voltage-dependent anion-selective channel protein 2	1.0E+07	7.0E+06	0.0118	2.0
Q9UHG2	PCSK1N	ProSAAS;KEP	3.0E+07	6.0E+06	0.0123	4.7
P54920	NAPA	Alpha-soluble NSF attachment protein	5.0E+06	2.0E+06	0.0123	2.2
Q01484	ANK2	Ankyrin-2	5.0E+07	2.0E+07	0.0126	2.1
P36543	ATP6V1E1	V-type proton ATPase subunit E 1	9.0E+06	4.0E+06	0.0133	2.3
O15075	DCLK1	Serine/threonine-protein kinase DCLK1	4.0E+06	9.0E+05	0.0142	4.3
P06727	APOA4	Apolipoprotein A-IV	3.0E+07	7.0E+07	0.015	0.5
Q9UI12	ATP6V1H	V-type proton ATPase subunit H	6.0E+06	3.0E+06	0.0154	2.2
P02042	HBD	Hemoglobin subunit delta	1.0E+07	1.0E+08	0.0155	0.1
P00918	CA2	Carbonic anhydrase 2	5.0E+05	7.0E+06	0.0155	0.1
Q9NTK5	OLA1	Obg-like ATPase 1	3.0E+06	7.0E+05	0.0169	3.5
P69905	HBA1	Hemoglobin subunit alpha	8.0E+08	4.0E+09	0.0179	0.2
P61803	DAD1	Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1	4.0E+06	1.0E+06	0.019	3.8
Q15063	POSTN	Periostin	1.0E+08	4.0E+07	0.0201	3.5
P01834	IGKC	Ig kappa chain C region	7.0E+07	2.0E+08	0.0202	0.4
P17174	GOT1	Aspartate aminotransferase, cytoplasmic	2.0E+07	7.0E+06	0.0223	2.4
P00915	CA1	Carbonic anhydrase 1	7.0E+06	4.0E+07	0.0232	0.2
P00450	CP	Ceruloplasmin	2.0E+07	5.0E+07	0.024	0.4
P02790	HPX	Hemopexin	5.0E+07	9.0E+07	0.0266	0.5
P17096	HMGA1	High mobility group protein HMG-I/HMG-Y	3.0E+07	6.0E+06	0.0271	5.2
Q15631	TSN	Translin	3.0E+06	7.0E+06	0.0287	0.5
P48163	ME1	NADP-dependent malic enzyme	2.0E+06	5.0E+05	0.0289	3.6
Q16799	RTN1	Reticulon-1	1.0E+07	5.0E+06	0.0307	2.5
P17677	GAP43	Neuromodulin	2.0E+08	9.0E+07	0.0311	2.1
O75348	ATP6V1G1	V-type proton ATPase subunit G 1	9.0E+06	4.0E+06	0.034	2.1
O00154	ACOT7	Cytosolic acyl coenzyme A thioester hydrolase	1.0E+07	4.0E+06	0.0342	2.8
Q9NZN4	EHD2	EH domain-containing protein 2	7.0E+06	5.0E+07	0.0347	0.1
P00747	PLG	Plasminogen	7.0E+06	2.0E+07	0.0357	0.4
P05156	CFI	Complement factor I	1.0E+06	7.0E+06	0.0368	0.2
O60716	CTNND1	Catenin delta-1	3.0E+06	5.0E+05	0.0374	6.3
Q1KMD3	HNRNPUL2	Heterogeneous nuclear ribonucleoprotein U-like protein 2	2.0E+06	4.0E+05	0.0377	4.2
P20591	MX1	Interferon-induced GTP-binding protein Mx1	8.0E+06	2.0E+06	0.0389	4.1
P40121	CAPG	Macrophage-capping protein	1.0E+07	2.0E+06	0.0401	5.2
Q01118	SCN7A	Sodium channel protein type 7 subunit alpha	4.0E+06	2.0E+07	0.0408	0.2
Q86Y82	STX12	Syntaxin-12	1.0E+06	0.0E+00	0.042	 
Q9P0J7	KCMF1	E3 ubiquitin-protein ligase KCMF1	3.4E+05	0.0E+00	0.0426	 
P05546	SERPIND1	Heparin cofactor 2	2.0E+06	7.0E+06	0.0493	0.3
P18509	ADCYAP1	Pituitary adenylate cyclase-activating polypeptide	7.0E+06	0.0E+00	0.0499	 


Figure Captions
Figure 1. Hierarchal clustering of PNI and non-PNI cancer samples (A) and invaded (IN) and non-invaded (NIN) nerve samples (B) according to their protein expression profiles. Each PNI sample clustered with its matching non-PNI sample, while all invaded nerves clustered together. Only one non-invaded nerve grouped with invaded nerves. Clustering was performed using ArrayTrackTM software. Scale represents peak intensities.
Figure 2. VGF (A-F) and SCG2 (G-L) and expression in pancreatic cancer. Both proteins are highly expressed in islets (arrow) (A/G). Representative images of PDAC nerves (N) illustrated a range of immunoreactivity. Extratumoral nerves typically showed no VGF (B) and SCG2 (H) expression, whereas intratumoral non-invaded nerves were weakly to moderately positive (C/I)); invaded nerves were strongly immunoreactive (D/J). VGF and SCG2 and expression was significantly higher in invaded compared to non-invaded nerves (E/K) and also significantly different between the three groups of nerves in PDAC (F/L)). *p<0.05, **p<0.01, ***p<0.001
Figure 3. Neurite growth in Transwell co-culture of PC12 cells with PDAC cell lines. PC12 co-cultured on their own were used as controls. NGF (50ng/ml) treatment was used as a positive control.  Representative images of PC12 neurite growth in co-culture with PDAC cell lines (scale bar = 50µm) (A). Cells extending neurites longer than the maximum diameter of the cell body were counted and represented as a percentage of total number of cells (B).  PC12 survival in transwell co-cultures using Annexin V/DAPI flow-cytometry assay. SF (serum free media) conditions were used as positive control for apoptosis whereas CM (complete media) and NGF (50ng/ml) were negative controls. Following 24 hours co-culture in serum-free-media, floating and attached PC12 cells were harvested, stained with Annexin and DAPI and analyzed as detailed in Methods section (C). The percentage of live cells (negative for both Annexin V and DAPI) in each condition was expressed relative to live cells in complete media (D). Western blot showing lower expression of Caspase 3 (E). ***p<0.001
Figure 4. VGF (A), Nestin and GAP43 protein expression (C) in PC12 cells in Transwell co-culture with PDAC cell lines or with PC12 as control. The representative Western blots are shown. VGF appear as a doublet at ~80 and ~90kDa, the lower band is thought to be a limited proteolytic product of the upper one  (A). Densitometry analysis of three independent experiments (B, C, D). Bands are normalized to GAPDH as a loading control and the results are expressed as fold change relative to control. *p<0.05; **p<0.01; ***p<0.001
Figure 5. PC12 cell contact co-cultures. PC12 cells survival measured using Annexin V/DAPI flow-cytometry assay in contact co-culture (A) and VGF protein expression in both transwell and contact co-cultures (B, C). *p<0.05; **p<0.01; ***p<0.001
Figure 6. Prevention of VGF induction in PC12 cells using siRNA silencing. Western blot confirming the maintenance of baseline levels of VGF upon conditioned medium (CnM) following siRNA (A). PC12 cell survival (using Annexin V/DAPI flowcytometry) (B), representative pictures of PC12 cell neurite extension (scale bar = 50µm) (C) and quantification of the neurite extension (D) following VGF siRNA or non-targeting siRNA treatment. *p<0.05


Supporting information

Supplementary information 1. Description of calculation of the purity of microdissected tissue samples. 

Figure S1.  Samples collected by laser microdissection. Matched PNI cancer cells, non-PNI cancer cells, invaded nerves and non-invaded nerves were laser microdissected from each of the five PDAC FFPE tissues. Top panel: before dissection; lower panel: verification of the dissected material.
Figure S2. Ingenuity Pathway Analysis of differentially regulated proteins in the nerve samples showing neuritogenesis-related functions and the proteins contributing to those functions (A) and several proteins contributing to the activation of cell survival and inhibition of apoptosis (B). Colours of the nodes reflect the level of activation/inhibition according to the colour key. The first number below the protein name indicates the p-value and the second a fold change. 
The four arrows that connect the nodes illustrate the Predicted relationships in the functional networks: orange/blue, when leading to activation/inhibition of the downstream node (e.g.protein); yellow indicates that the found relationship in the submitted data are inconsistent with the prediction based on Ingenuity Knowledge Base; grey color indicates that no predictions could be made from our proteomics data based on Ingenuity Knowledge Base.
Figure S3. VGF gene expression in PC12 cells co-cultured with indicated PDAC cell lines. Values are relative to PC12 only co-culture. *p<0.05, **p<0.01
Figure S4. Representative example of FACS sorting of contact co-cultures to isolate PC12 cells (P4, CMFDA stained) (A). Sorted PC12 cells were checked again using FACS to verify their purity (B).

Figure S5. Immunocytochemistry staining of post-sorted PC12 cells using anti-CK19 antibody. Representative images (x400 magnification) of post-sorted PC12 cells (right panel), the lack of CK19 staining indicates high degree of purity. PC12 cells and PDAC cells on their own were used as negative and positive controls, respectively (left panel). DAPI was used to stain nuclei.

Table  S1. Clinical details of PDAC cases used for laser microdissection (highlighted in light green) and proteomics analysis. TNM: tumor size, lymph node, distant metastases. UICC: Union for International Cancer Control.
Table S2. List of 1,628 non-redundant proteins identified in cancer invading the nerves (PNI 1-5) and non-invading cancer (non-PNI 1-5)
Table S3. List of differentially expressed proteins in invasive and non-invasive cancer. PNI: invasive cancer in the nerves, non-PNI cancer not invading nerves. FC: fold change
Table S4. List of 923 non-redundant proteins identified in invaded (IN 1-5) and non-invaded (NIN 1-5) nerves.
Table S5. List of proteins up-regulated in invaded nerves compared to non-invaded nerves
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